Quantum BioPharma is trading at $3.23, down 7.18%, after no fresh company-specific catalyst was identified for August 13, 2026.
- The recent FDA clearance for Lucid-MS Phase 2 was announced August 10, not overnight.
- Earnings are listed for August 13, but no results were available at 4:11 AM.
- Broader futures are nearly flat, offering limited market-wide explanation.